
An Australian-American medical giant leading the world in products to treat sleep apnoea is branching out into another major sleep disorder - restless leg syndrome.
Resmed has bought Noctrix Health, a California-based company that makes a wearable device to treat Will-Ekbom Disease for $US360 million ($500 million).